CBCCanada· English
Ended event: this page keeps the last analysis, of . It is no longer updated.
Cheap version of HIV-prevention shot raising hope in low-income countries
Covered by 13 outlets from 11 countries, in 5 languages · 2 Nov 2026 – 4 Nov 2026
Key points
Key facts
The U.S. Food and Drug Administration (FDA) approved a generic, low-cost version of a twice-yearly HIV prevention injection, which is the generic form of lenacapavir, a treatment originally developed by Gilead. This approval, announced by Dr. Reddy's Laboratories and Unitaid, makes the drug available in 120 countries for $40 per person per year, facilitating access to this major advancement in low- and middle-income countries. This treatment allows for a 99.9% reduction in the risk of HIV transmission.
Automatic summary · See the sources · Report an error
- Estados Unidos aprueba la versión genérica y más económica de un tratamiento contra el VIH Headline of the event's most representative article · ABC · 2 Nov 2026
- Where it happened: United States. See on the map
- Reported by 13 outlets from 11 countries, in 5 languages, between 2 Nov 2026 and 4 Nov 2026.13 articles · See all headlines
Key points built automatically from headlines and coverage data. echoblic copies no article text.
Go to the sources
TV5MondeFrance· French
Feu vert américain pour un traitement abordable contre le VIH pour les pays en développement
Kleine ZeitungAustria· German
Generikum von HIV-Prophylaxe-Spritze erhält US-Genehmigung
Original headlines, attributed to their outlets and reproduced as published.
Locate · connect · understand
Places and sources on the map
Where the event took place
Where it happened
Where it happened and where the outlets are based are two different pieces of information.
Where do the outlets publish?
Diamond: where the event took place; light square: another place involved, joined by a line. Grey circles: number of outlets published in each country that cover the event; they do not show that country's opinion. No borders are drawn. Basemap © OpenStreetMap contributors, OpenFreeMap.
Follow the story
Coverage timeline
- First article seen (Diario Libre)
- Covered by 10 outlets
- 2 new outlets
- 1 new outlet
Check · compare · dig deeper
Every source, clearly
The original headlines, their outlet, its country and language. Direct access to what was published.
13 outlets · 13 articles
Diario LibreDominican Republic· Spanish
EE.UU. aprueba tratamiento económico contra el VIH
TV5MondeFrance· French
Feu vert américain pour un traitement abordable contre le VIH pour les pays en développement
ABCSpain· Spanish
Estados Unidos aprueba la versión genérica y más económica de un tratamiento contra el VIH
franceinfoFrance· French
"Une avancée extraordinaire pour la santé mondiale" : les Etats-Unis approuvent la version générique d'un traitement préventif contre le VIH
Sky News ArabiaUnited Arab Emirates· Arabic
الوقاية من فيروس الإيدز.. نسخة أرخص لـ120 دولة
Euronews (AR)France· Arabic
بـ40 دولارًا سنويًا.. موافقة أميركية مبدئية على نسخة منخفضة التكلفة من حقنة للوقاية من فيروس" الإيدز"
Sada El BaladEgypt· Arabic
موافقة أمريكية لإنتاج دواء جنيس للوقاية من فيروس الإيدز.. سعره وموعد طرحه
Arab48Israel· Arabic
أميركا تمنح موافقة مبدئية لنسخة منخفضة الكلفة من دواء الوقاية من فيروس نقص المناعة
Method
echoblic automatically groups articles from different outlets by event, offers a summary and gives access to the original sources. Articles about the same fact are automatically grouped into one event, in every language. Each outlet counts once, whatever its number of articles. The country, owner and reputation of an outlet are never used. Latest analysis: .